OM
Opaleye Management Inc. bought $159K of GRCE stock
Opaleye Management Inc., 10% owner of Grace Therapeutics, Inc. (GRCE), bought 87,801 shares of GRCE stock worth $159K, per an SEC Form 4 filed Oct 26, 2026.
It was an open-market purchase.
The trade happened on Oct 22, 2026, 4 days before it was made public.
GRCE has moved -5.5% since the trade date, from $1.92 to $1.81 (Nov 13, 2026 close).
- Traded
- Oct 22, 2026
- Disclosed
- Oct 26, 2026
- Filing delay
- 4 days
- Price since
- -5.5%
- Role
- 10% owner
- Source
- SEC Form 4